Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome

Human Reproduction

Volumn 32, Issue 2, 2017, Pages 354-361

  Wei, Daimin ^a,b   Shi, Yuhua ^a,b   Li, Jing ^a,b   Wang, Ze ^a,b   Zhang, Lin ^a,b   Sun, Yun ^c   Zhou, Hong ^d   Xu, Yuping ^e   Wu, Chunxiang ^f   Liu, Ling ^g   Wu, Qiongfang ^h   Zhuang, Lili ⁱ   Du, Yanzhi ^c   Li, Weiping ^c   Zhang, Heping ^j   Legro, Richard S ^k   Chen, Zi Jiang ^a,b,c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Maternal and Child Health Hospital in Guangxi   (China)

^e ANHUI MEDICAL UNIVERSITY   (China)

^f THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^g Jinghua Hospital   (China)

^h JIANGXI PROVINCIAL MATERNAL AND CHILD HEALTH HOSPITAL   (China)

ⁱ YANTAI YUHUANGDING HOSPITAL   (China)

^j YALE UNIVERSITY   (United States)

^k PENN STATE COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Embryo transfer; Live birth; Oral contraceptives; Polycystic ovary syndrome; Progestin

Indexed keywords

GESTAGEN; GONADOTROPIN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; HUMAN; IN VITRO FERTILIZATION; LIVE BIRTH; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; SECONDARY ANALYSIS; BIRTH RATE; CLINICAL TRIAL; MULTICENTER STUDY; OVULATION INDUCTION; PREGNANCY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BIRTH RATE; CONTRACEPTIVES, ORAL, HORMONAL; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTINS; TREATMENT OUTCOME;

EID: 85014463915     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dew325     Document Type: Article

References (27)

1. Cedrin-Durnerin I, Bstandig B, Parneix I, Bied-Damon V, Avril C, Decanter C, Hugues JN Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod 2007; 22: 109-116.
2. Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med 2016; 375:523-533.
3. Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception 1979; 20:475-487.
4. Creus M, Ordi J, Fabregues F, Casamitjana R, Carmona F, Cardesa A, Vanrell JA, Balasch J. The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod 2003; 18:683-693.
5. Diamond MP, Kruger M, Santoro N, Zhang H, Casson P, Schlaff W, Coutifaris C, Brzyski R, Christman G, Carr BR et al. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol 2012; 119:902-908.
6. Edelman AB, Carlson NE, Cherala G, Munar MY, Stouffer RL, Cameron JL, Stanczyk FZ, Jensen JT Impact of obesity on oral contraceptive pharma-cokinetics and hypothalamic-pituitary-ovarian activity. Contraception 2009; 80:119-127.
7. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril 2010; 94:2382-2384.
8. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001; 179:39-46.
9. Huirne JA, van Loenen AC, Donnez J, Pirard C, Homburg R, Schats R, McDonnell J, Lambalk CB Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 2006; 13:235-245.
10. Jones CA, Garbedian K, Dixon M, Murphy K, Shapiro H. Randomized trial comparing the effect of endometrial shedding with medroxyprogesterone acetate with random start of clomiphene citrate for ovulation induction in oligo-ovulatory and anovulatory women. J Obstet Gynaecol Can 2016; 38:458-464.
11. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006; 21:352-357.
12. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014b; 371:119-129.
13. Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC et al. Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J Clin Endocrinol Metab 2015; 100:4048-4058.
14. Legro RS, Dodson WC, Kunselman AR, Stetter CM, Kris-Etherton PM, Williams NI, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB et al. Benefit of delayed fertility therapy with preconception weight loss over immediate therapy in obese women with PCOS. J Clin Endocrinol Metab 2016; 101: 2658-2666.
15. Legro RS, Wu X, Barnhart KT, Farquhar C, Fauser BC, Mol B. Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement. Hum Reprod 2014a; 29: 2075-2082.
16. Linn S, Schoenbaum SC, Monson RR, Rosner B, Ryan KJ Delay in conception forformer'pill' users. JAMA 1982; 247:629-632.
17. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106:6-15.
18. Lopez LM, Bernholc A, Chen M, Grey TW, Otterness C, Westhoff C, Edelman A, Helmerhorst FM Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2016.: CD008452.
19. McCartney CR, Marshall JC CLINICAL PRACTICE. Polycystic ovary syndrome. N Engl J Med 2016; 375:54-64.
20. Meldrum DR, Scott RT Jr, Levy MJ, Alper MM, Noyes N. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril 2009; 91: 1963-1965.
21. Ozgur K, Berkkanoglu M, Bulut H, Humaidan P, Coetzee K. Agonist depot versus OCP programming of frozen embryo transfer a retrospective analysis of freeze-all cycles. J Assist Reprod Genet 2016; 33:207-214.
22. Rombauts L, Healy D, Norman RJ A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 2006; 21:95-103.
23. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril 2014; 102:3-9.
24. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril 2011; 96:344-348.
25. Shi Y, Wei D, Liang X, Sun Y, Liu J, Cao Y, Zhang B, Legro RS, Zhang H, Chen ZJ Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multi-center, prospective, randomized controlled clinical trial. Trials 2014; 15: 154.
26. Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer JA Oral contraceptive pill, progestogen or estrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev 2010.: CD006109.
27. Weinerman R, Mainigi M. Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertil Steril 2014; 102:10-18.